AI-based drug discovery company Recursion raises $121M at a $646M valuation; VCs invested about $1B in AI drug discovery startups in 2018, up from $237M in 2016 (Robert Langreth/Bloomberg)
AI-based drug discovery company Recursion raises $121M at a $646M valuation; VCs invested about $1B in AI drug discovery startups in 2018, up from $237M in 2016 — Alphabet's DeepMind cracked a problem that long vexed biologists, heating up a technological arms race in health care
from Techmeme https://ift.tt/2xQQy9r
No comments
Post a Comment